Search research articles
Contact Us
Filters
Showing results (11-20 of 46) with videos related to
Page
of 5
Sort By:
Respiratory Medicine
|
November 28, 2025
Automated artificial intelligence detection of early or under-diagnosed interstitial lung disease by computed tomography in the COPDGene trial
Stephanie J Chen, Angad Kalra, Michael Muelly, et al.
Respiratory Medicine
|
November 26, 2019
The senescence-associated matricellular protein CCN1 in plasma of human subjects with idiopathic pulmonary fibrosis
Tejaswini Kulkarni, Ashish R Kurundkar, Young-Il Kim, et al.
Journal of Digital Imaging
|
September 5, 2023
Pulmonary Surface Irregularity Score as a New Quantitative CT Marker for Idiopathic Pulmonary Fibrosis-a Pilot Study
Asser M Abou Elkassem, Rafah Mresh, Ahmed Farag, et al.
JCI Insight
|
February 7, 2020
Monocyte-derived alveolar macrophage apolipoprotein E participates in pulmonary fibrosis resolution
Huachun Cui, Dingyuan Jiang, Sami Banerjee, et al.
American Journal of Respiratory and Critical Care Medicine
|
November 16, 2013
Loss of salmeterol bronchoprotection against exercise in relation to ADRB2 Arg16Gly polymorphism and exhaled nitric oxide
Matteo Bonini, Perdita Permaul, Tejaswini Kulkarni, et al.
Respiratory Care
|
January 28, 2016
Flexible Bronchoscopy Is Safe and Effective in Adult Subjects Supported With Extracorporeal Membrane Oxygenation
Nirmal S Sharma, Timothy Peters, Tejaswini Kulkarni, et al.
ERJ Open Research
|
July 22, 2025
Deupirfenidone (LYT-100) in post-acute sequelae of SARS-CoV-2 with respiratory complications
Tejaswini Kulkarni, Joel Santiaguel, Raminder Aul, et al.
ERJ Open Research
|
October 1, 2024
Objective measurement of cough in pulmonary fibrosis: a cohort study - ImpaCT
Jad Kebbe, Simon P Hart, Robert J Kaner, et al.
BMC Pulmonary Medicine
|
March 21, 2024
Design of the STRIVE-IPF trial- study of therapeutic plasma exchange, rituximab, and intravenous immunoglobulin for acute exacerbations of idiopathic pulmonary fibrosis
Tejaswini Kulkarni, Gerard J Criner, Daniel J Kass, et al.
Research Square
|
March 11, 2024
Design of the STRIVE-IPF Trial- Study of Therapeutic Plasma Exchange, Rituximab, and Intravenous Immunoglobulin for Acute Exacerbations of Idiopathic Pulmonary Fibrosis
Tejaswini Kulkarni, Gerard J Criner, Daniel J Kass, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 46) with videos related to
Sort By:
Page
of 5
Respiratory Medicine
|
November 28, 2025
Automated artificial intelligence detection of early or under-diagnosed interstitial lung disease by computed tomography in the COPDGene trial
Stephanie J Chen, Angad Kalra, Michael Muelly, et al.
Respiratory Medicine
|
November 26, 2019
The senescence-associated matricellular protein CCN1 in plasma of human subjects with idiopathic pulmonary fibrosis
Tejaswini Kulkarni, Ashish R Kurundkar, Young-Il Kim, et al.
Journal of Digital Imaging
|
September 5, 2023
Pulmonary Surface Irregularity Score as a New Quantitative CT Marker for Idiopathic Pulmonary Fibrosis-a Pilot Study
Asser M Abou Elkassem, Rafah Mresh, Ahmed Farag, et al.
JCI Insight
|
February 7, 2020
Monocyte-derived alveolar macrophage apolipoprotein E participates in pulmonary fibrosis resolution
Huachun Cui, Dingyuan Jiang, Sami Banerjee, et al.
American Journal of Respiratory and Critical Care Medicine
|
November 16, 2013
Loss of salmeterol bronchoprotection against exercise in relation to ADRB2 Arg16Gly polymorphism and exhaled nitric oxide
Matteo Bonini, Perdita Permaul, Tejaswini Kulkarni, et al.
Respiratory Care
|
January 28, 2016
Flexible Bronchoscopy Is Safe and Effective in Adult Subjects Supported With Extracorporeal Membrane Oxygenation
Nirmal S Sharma, Timothy Peters, Tejaswini Kulkarni, et al.
ERJ Open Research
|
July 22, 2025
Deupirfenidone (LYT-100) in post-acute sequelae of SARS-CoV-2 with respiratory complications
Tejaswini Kulkarni, Joel Santiaguel, Raminder Aul, et al.
ERJ Open Research
|
October 1, 2024
Objective measurement of cough in pulmonary fibrosis: a cohort study - ImpaCT
Jad Kebbe, Simon P Hart, Robert J Kaner, et al.
BMC Pulmonary Medicine
|
March 21, 2024
Design of the STRIVE-IPF trial- study of therapeutic plasma exchange, rituximab, and intravenous immunoglobulin for acute exacerbations of idiopathic pulmonary fibrosis
Tejaswini Kulkarni, Gerard J Criner, Daniel J Kass, et al.
Research Square
|
March 11, 2024
Design of the STRIVE-IPF Trial- Study of Therapeutic Plasma Exchange, Rituximab, and Intravenous Immunoglobulin for Acute Exacerbations of Idiopathic Pulmonary Fibrosis
Tejaswini Kulkarni, Gerard J Criner, Daniel J Kass, et al.
Page
of 5